glp-1 drugs key developments 2025 Weight Loss Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care GLP-1 Market Trends and Global
Description
The idea of simultaneously activating both the GIP and GLP-1 receptors seems appealing for treatment of T2DM since it may significantly boost insulin secretion and improve insulin sensitivity
T2DM, Type 2 diabetes
The medications do have side effects
Effects of steatotic liver disease and cardiometabolic risk factors in MASLD on adverse pregnancy outcomes
